Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 116

1.

[Evaluation of optimal dosage of heparin in hemodialysis patients by thromboelastograph].

Yang ST, Wu H, Gao XY, Hu J, Xiao YF.

Beijing Da Xue Xue Bao. 2013 Aug 18;45(4):625-9. Chinese.

2.

[Appropriate dosage of unfraction heparin and low molecular weight heparin in hemodialysis patients].

Xiao Q, Sun XF, Zhang D, Ma ZF, Wu MG, Wang H, Chen XM.

Zhonghua Yi Xue Za Zhi. 2010 Jan 19;90(3):187-91. Chinese.

PMID:
20356555
3.

Usefulness of thrombelastography for dosage monitoring of low molecular weight heparin and unfractionated heparin during hemodialysis.

Shinoda T, Arakura H, Katakura M, Shirota T, Nakagawa S.

Artif Organs. 1990 Dec;14(6):413-5.

PMID:
2177970
4.

Conventional coagulation and thromboelastograph parameters and longevity of continuous renal replacement circuits.

Holt AW, Bierer P, Glover P, Plummer JL, Bersten AD.

Intensive Care Med. 2002 Nov;28(11):1649-55. Epub 2002 Oct 8.

PMID:
12415456
5.
7.

Anticoagulant efficacy of PEG-Hirudin in patients on maintenance hemodialysis.

Pöschel KA, Bucha E, Esslinger HU, Ulbricht K, Nörtersheuser P, Stein G, Nowak G.

Kidney Int. 2004 Feb;65(2):666-74.

8.

[Prevention of thrombogenesis in the extracorporeal circuit of hemodialysis with a low molecular heparin: standardization of the dosage with a better hemorrhagic risk/effectiveness ratio].

Barata JD, Oliveira C, Bruges M, Gusmão L, Santana A, Ponce P, Simões J, Freire I, Crespo F, da Silva AN.

Acta Med Port. 1992 Feb;5(2):65-70. Portuguese.

9.

Variations in the circulating heparin levels during maintenance hemodialysis in patients with end-stage renal disease.

Kaneva K, Bansal V, Hoppensteadt D, Cunanan J, Fareed J.

Clin Appl Thromb Hemost. 2013 Jul-Aug;19(4):449-52. doi: 10.1177/1076029613479820. Epub 2013 Mar 4.

PMID:
23463188
10.

Use of low-dose low molecular weight heparin in hemodialysis.

Lai KN, Wang AY, Ho K, Szeto CC, Li M, Wong LK, Yu AW.

Am J Kidney Dis. 1996 Nov;28(5):721-6.

PMID:
9158210
11.

[Impact of heparin on coagulation index during the therapy of molecular adsorbent recirculating system in patients with liver failure].

Yuan S, Zhou Y, Tan D, Li D, Zhou T, Xie Q, Fan J.

Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2011 Sep;36(9):830-5. doi: 10.3969/j.issn.1672-7347.2011.09.003. Chinese.

12.

Dosage, anticoagulant, and antithrombotic effects of heparin and low-molecular-weight heparin in the treatment of deep vein thrombosis.

Harenberg J, Stehle G, Blauth M, Huck K, Mall K, Heene DL.

Semin Thromb Hemost. 1997;23(1):83-90.

PMID:
9156415
13.

Use of fondaparinux as an anticoagulant during hemodialysis: a preliminary study.

Sombolos KI, Fragia TK, Gionanlis LC, Veneti PE, Bamichas GI, Fragidis SK, Georgoulis IE, Natse TA.

Int J Clin Pharmacol Ther. 2008 Apr;46(4):198-203.

PMID:
18397694
14.

Low-dose heparin in routine hemodialysis monitored by activated partial thromboplastin time.

Shapiro WB, Faubert PF, Porush JG, Chou SY.

Artif Organs. 1979 Feb;3(1):73-7.

PMID:
435127
15.

Effect of body mass index on bleeding frequency and activated partial thromboplastin time in weight-based dosing of unfractionated heparin: a retrospective cohort study.

Bauer SR, Ou NN, Dreesman BJ, Armon JJ, Anderson JA, Cha SS, Oyen LJ.

Mayo Clin Proc. 2009 Dec;84(12):1073-8. doi: 10.4065/mcp.2009.0220.

16.

The anticoagulant and hemorrhagic effects of DHG, a new depolymerized holothurian glycosaminoglycan, on experimental hemodialysis in dogs.

Minamiguchi K, Kitazato KT, Sasaki E, Nagase H, Kitazato K.

Thromb Haemost. 1997 Jun;77(6):1148-53.

PMID:
9241748
17.
18.

[Anticoagulation in hemodialysis with a single dose of low molecular weight heparin].

Vukusich A, Avalos C, Orellana G, Cifuentes C, Rivas J, Calderón F.

Rev Med Chil. 1995 Jun;123(6):735-41. Spanish.

PMID:
8525227
19.

Dermatan sulfate: an alternative to unfractionated heparin for anticoagulation in hemodialysis patients.

Vitale C, Berutti S, Bagnis C, Soragna G, Gabella P, Fruttero C, Marangella M.

J Nephrol. 2013 Jan-Feb;26(1):158-63. doi: 10.5301/jn.5000105.

PMID:
22419236
20.

Hemodialysis using heparin-bound Hemophan in patients at risk of bleeding.

Lee KB, Kim B, Lee YH, Yoon SJ, Kang WH, Huh W, Kim DJ, Oh HY, Kim YG.

Nephron Clin Pract. 2004;97(1):c5-10.

PMID:
15153761
Items per page

Supplemental Content

Write to the Help Desk